SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is a hot topic amidst a sharp divergence of investor sentiment, primarily driven by its ambitious AI infrastructure expansion and substantial debt. While some highlight its impressive cloud backlog and potential for major AI contracts, others are concerned about increased capital expenditures, recent revenue performance, and a bondholder lawsuit related to debt financing, leading to fervent debate about its future trajectory.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed Inc. is surging due to its subsidiary, Lucid Diagnostics, securing a significant contract with the U.S. Department of Veterans Affairs for its EsoGuard esophageal DNA test. This news has ignited intense discussion among traders, who are actively debating the potential for continued upside driven by its low float and the strategic importance of expanding esophageal cancer screening across the VA healthcare system, though some express skepticism given the company's past volatility.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending following its Q4 earnings report, which, despite solid membership and ad revenue growth, was met with investor concern over a conservative Q1 outlook and the all-cash Warner Bros. Discovery acquisition proposal. The community is sharply divided, with many seeing the stock as oversold and a long-term buying opportunity, while others express fears of ongoing downside due to acquisition-related debt and a shift in company priorities. The market continues to weigh Netflix's content strategy and future growth trajectory amidst a competitive streaming landscape.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is currently trending following a significant 10-year data center lease agreement with Riot Platforms, providing 25 megawatts of capacity with options for substantial expansion, signaling AMD's growing role in AI infrastructure. The community is highly optimistic, noting AMD's consistent strength even on broader market downturns and anticipating continued market share gains amidst surging demand for AI compute.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing a significant surge, driven by widespread anticipation surrounding its impending earnings report and recent analyst upgrades. The community is actively discussing the potential for a substantial short squeeze and a sustained upward trajectory, fueled by confidence in its manufacturing advancements and increasing AI server demand. While many foresee a strong breakout, others remain watchful for a 'sell the news' reaction after its impressive run.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is generating significant discussion as the company reveals strategic progress with record 2025 production and deliveries, a new Rockwell Automation partnership for its Saudi facility, and a robotaxi alliance debut at CES. Despite these operational advancements, the stock faces intense investor scrutiny due to reports of seeking international funding beyond its primary backer and persistent dilution, driving strong volatility and concerns about its financial trajectory.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending amidst an unprecedented and accelerating shortage of memory chips, particularly High-Bandwidth Memory (HBM), driven by robust AI infrastructure demand. The community is actively discussing whether its strong performance, fueled by strategic acquisitions and production expansions, signals a sustainable "supercycle" or if the stock is overextended in a historically cyclical industry. Investors are also noting its compelling valuation compared to other AI-driven semiconductor peers.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is generating significant conversation following a notable share price decline, leading to a stark division in community sentiment. Bearish investors express frustration over perceived manipulation and competition from larger players in the health and weight-loss markets. Meanwhile, bullish participants are emphasizing the company's underlying growth, strategic vertical integration in personalized healthcare, and see current levels as a compelling long-term buying opportunity.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is rallying sharply, primarily driven by President Trump's statements from Davos, which included a softened stance on Greenland and optimistic market outlook. The community is actively debating this rapid "V" shaped recovery, with many confidently buying dips amidst ongoing discussions about an "AI meltup" propelling the tech-heavy index despite some skepticism about market manipulation.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD, a leveraged inverse natural gas ETF, is trending due to extreme volatility in the natural gas market driven by severe cold weather forecasts across the U.S. This recently caused a dramatic price surge in natural gas, leading to a sharp decline in KOLD, prompting active community debate on whether the ETF has bottomed for a rebound or faces further downside, solidifying its 'Widowmaker' reputation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 6.5% - Time to Sell?

NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Down 6.5% - What's Next...

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 6.4% - Time to Sell?

NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Down 6.4% - Here's What Happened...

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Rating of "Moderate Buy" from Analysts

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the ten research firms that are covering the firm, MarketBeat reports. One...

NewAmsterdam Pharma (NASDAQ:NAMS) CAO Sells $2,719,986.57 in Stock

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CAO Louise Frederika Kooij sold 75,117 shares of the firm's stock in a transaction on Tuesday, December 23rd. The stock was sold at an...

NewAmsterdam Pharma (NASDAQ:NAMS) CAO Sells $928,072.48 in Stock

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CAO Louise Frederika Kooij sold 26,011 shares of the business's stock in a transaction dated Wednesday, December 24th. The shares were...

Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) CAO Sells 43,872 Shares of Stock

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CAO Louise Frederika Kooij sold 43,872 shares of the firm's stock in a transaction on Friday, December 26th. The shares were sold at...

Louise Frederika Kooij Sells 75,117 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CAO Louise Frederika Kooij sold 75,117 shares of the company's stock in a transaction on Tuesday, December 23rd. The shares were sold...

NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Stifel Nicolaus increased their target price on shares of NewAmsterdam Pharma from $44.00 to $50.00 and gave the company a "buy" rating in a research note on Tuesday...

Frazier Life Sciences Management L.P. Has $300.75 Million Stock Position in NewAmsterdam Pharma Company N.V. $NAMS

Frazier Life Sciences Management L.P. raised its holdings in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 3.0% in the 2nd quarter, according to its most recent Form 13F filing with...

NewAmsterdam Pharma Company N.V. $NAMS Holdings Lifted by Maverick Capital Ltd.

Maverick Capital Ltd. raised its position in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 178.8% during the 2nd quarter, according to its most recent disclosure with the Securities...

NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. Its lead product candidate, Obicetrapib, is a next-generation, oral, low-dose cholesteryl ester transfer protein inhibitor, which will be used to prevent major adverse cardiovascular events. The company was founded on June 10, 2022 and is headquartered in Naarden, the Netherlands.

NewAmsterdam Pharma Company NV

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.39	--	--	N/A
Q3 '25	-$0.56	-$0.61	-8.41%	MISSED
Q2 '25	-$0.20	-$0.15	25.76%	BEAT
Q1 '25	-$0.35	--	--	N/A
Q4 '24	-$0.76	--	--	N/A

NAMS
NewAmsterdam Pharma Company NV

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest NAMS News

NAMSNewAmsterdam Pharma Company NV